Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Agenus Inc
(NQ:
AGEN
)
13.07
+0.55 (+4.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Agenus Inc
< Previous
1
2
3
4
5
Next >
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
Via
Benzinga
Agenus (AGEN) Q1 2023 Earnings Call Transcript
May 09, 2023
AGEN earnings call for the period ending March 31, 2023.
Via
The Motley Fool
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
April 17, 2023
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.
Via
The Motley Fool
Agenus' Investigational Cancer Combo Therapy Shows 33% Durable Responses In Ovarian Cancer
March 27, 2023
Via
Benzinga
Why Agenus Stock Is Slumping This Week
March 23, 2023
The biotech may have to raise capital soon.
Via
The Motley Fool
Agenus (AGEN) Q4 2022 Earnings Call Transcript
March 14, 2023
AGEN earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
Via
Benzinga
Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today
April 04, 2023
Macro headwinds are weighing on risk-laden biotech stocks today.
Via
The Motley Fool
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Earnings Preview For Agenus
March 13, 2023
Via
Benzinga
Looking Into Agenus's Return On Capital Employed
December 05, 2022
Via
Benzinga
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate
January 23, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via
Benzinga
7 Hot Stocks to Book Profits In Before 2023
December 19, 2022
With major macroeconomic headwinds appearing on the horizon, it’s time for investors to consider the hot stocks to book profits in.
Via
InvestorPlace
Why Shares of Agenus Rose 12.5% on Friday
December 02, 2022
Agenus presented data this week on a combination therapy.
Via
The Motley Fool
Miniso Group, Monday.com And Other Big Gainers From Monday
November 15, 2022
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Agenus (AGEN) Q3 2022 Earnings Call Transcript
November 08, 2022
AGEN earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
October 12, 2022
Via
Benzinga
Why Agenus Stock Rose 18.4% on Thursday
October 06, 2022
The company's shares climbed with help from insider buying.
Via
The Motley Fool
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 14, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
10 Best Medical Stocks Under $5
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
October 10, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Via
Benzinga
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday
October 07, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.
Via
InvestorPlace
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Via
Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Via
Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...
Via
Benzinga
Agenus Begins Mid-Stage Global Studies On Colorectal And Skin Cancer Candidate
September 12, 2022
Agenus (NASDAQ: AGEN) has initiated Phase 2 ACTIVATE trials of botensilimab to advance globally in metastatic patients who have progressed on available therapies. This global Phase 2 program include...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.